Endo completes acquisition of Grupo Farmaceutico Somar®
Endo announced it has completed the acquisition of Grupo Farmaceutico Somar®), a leading, privately owned specialty pharmaceuticals company based in Mexico City. The combination of Somar and Endo advances Endo's position and platform for growth in key emerging markets in Latin America. July 24, 2014